| Product Name | NebuSelect™ Recombinant Mouse PRLR, His-tag |
|---|---|
| Catalog Number | NBL-242184 |
| Alias/Synonyms | PRLR; PRL-R; HPRL; MFAB; Prolactin R |
| Appearance | see COA |
| Molecule Weight | Gln20-Asp229 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Q08501-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242184-100ug | 100ug | Inquire | Inquire | |
| NBL-242184-1mg | 1mg | Inquire | Inquire | |
| NBL-242184-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse PRLR, His-tag
Catalog#:
NBL-242184
Description:
NebuSelect™ Recombinant Mouse PRLR, His-tag(Cat#NBL-242184) is expressed in HEK293 with His tag at the C-Terminus.It contains Gln20-Asp229.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 25.7 kDa. Due to glycosylation, the protein migrates to 38-45 kDa based on Bis-Tris PAGE result.
Target Name:
PRLR; PRL-R; HPRL; MFAB; Prolactin R
Target Information:
Prolactin receptor (PRLR) is highly expressed in a subset of human breast cancer and prostate cancer, which makes it a potential target for cancer treatment. In clinical trials, the blockade of PRLR was shown to be safe but with poor efficacy. It is therefore urgent to develop new therapies against PRLR target. Bispecific antibodies (BsAbs) could guide immune cells toward tumor cells, and produced remarkable effects in some cancers.
Amino Acid Sequence:
Gln20-Asp229
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.